Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer
Clinical trial NCT06136910 · UNKNOWN
Trial details
- NCT number
- NCT06136910
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2024-05-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.